Local recurrences of differenciated thyroid carcinoma: Diagnosis-treatment;Récidives locorégionales des cancers différenciés de la thyroïde: Diagnostic-traitement

Annales de Chirurgie

Volumn 127, Issue 1, 2002, Pages 35-39

  Visset, J ^a   Hamy, A ^a   Mirallie, E ^a   Paineau, J ^a  

^a CHU de Nantes   (France)

Author keywords

Local recurrence; Serum thyroglobuline; Surgery; Thyroid carcinoma

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIOISOTOPE THERAPY; REOPERATION; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TREATMENT INDICATION;

EID: 17544389389     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-3944(01)00672-1     Document Type: Article

References (28)

1. Devenir des récidives cervicales de cancer papillaire ou vésiculaire de la thyroïde
2. Prognostic factors in patients with recurrent differentiated thyroid carinoma
3. Recurrent thyroid cancer. Role of surgery versus radioactive lodine
4. Current results of conservative surgery for differentiated thyroid carcinoma
5. Differentiated thyroid cancer. Reexamination of risks groups and outcome of treatment
6. Pronostic factors in papillary carcinoma of the thyroid
7. Clinical outcome of patients with papillary thyroid carcinoma who have recurrent after initial radio-active iodine therapy
8. Medical progress: Papillary and follicular thyroid carcinoma
9. Distant metastases in papillary thyroid cancer. A review of 91 patients
10. Papillary thyroid cancer treated at the Mayo Clinic 1946 through 1970: Initial manifestations, pathologic findings, therapy and outcome
11. Prospective management of nodal metastases in differentiated thyroid cancer
12. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment
13. Management of local recurrence in well-differentiated thyroid carcinoma
14. Follow-up study of postoperative patients with thyroid cancer thallium 201 scintigraphy and serum thyroglobulin measure
15. Survival of differentiated thyroid carcinoma studied in 500 patients
16. The use of radioactive iodine in patients with papillary and follicular thyroid cancer
17. Are post therapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
18. Rechutes ganglionnaires des cancers thyroïdiens différenciés
19. False positive 131 I whole bodyscans in thyroid cancer
20. Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer
21. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin
22. Utility of fluorine-18-fluorodeoxyglucose position emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels
23. Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin level and negative radioiodine scans
24. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radiolodine
25. Evaluation and treatment of persistent thyroglobulinemia in patients with well differentiated thyroid cancer
26. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
27. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma